LEF1 haploinsufficiency causes ectodermal dysplasia

Abstract Ectodermal dysplasias are a family of genodermatoses commonly associated with variants in the ectodysplasin/NF‐κB or the Wnt/β‐catenin pathways. Both pathways are involved in signal transduction from ectoderm to mesenchyme during the development of ectoderm‐derived structures. Wnt/β‐catenin pathway requires the lymphoid enhancer‐binding factor 1 (LEF1), a nuclear mediator, to activate target gene expression. In mice, targeted inactivation of the LEF1 gene results in a complete block of development of multiple ectodermal appendages. We report two unrelated patients with 4q25 de novo deletion encompassing LEF1 , associated with severe oligodontia of primary and permanent dentition, hypotrichosis and hypohidrosis compatible with hypohidrotic ectodermal dysplasia. Taurodontism and a particular alveolar bone defect were also observed in both patients. So far, no pathogenic variants or variations involving the LEF1 gene have been reported in human. We provide further evidence for LEF1 haploinsufficiency role in ectodermal dysplasia and delineate its clinical phenotype.